News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Matteo Lambertini: What a big honor to have Sara Tolaney at our ESMOYOC session
Photo from Matteo Lambertini/X
May 18, 2024, 10:02

Matteo Lambertini: What a big honor to have Sara Tolaney at our ESMOYOC session

Matteo Lambertini, Medical Oncologist at San Martino, shared on X: .

“What a big honor to have Sara Tolaney from Dana-Farber Cancer Institute at our ESMOYOC session discussing the many challenges faced in the case of early recurrence after (neo)adjuvant treatment of triple-negative breast cancer.”

Source: Matteo Lambertini/X

Breast Cancer cancer Dana-Farber Cancer Institute ESMO ESMOBreast24 ESMOYOC Matteo Lambertini OncoDaily Oncology San Martino Sara Tolaney triple-negative breast cancer
Special Coverage
Blog
Jan 16, 2025, 23:04
Arturo Loaiza-Bonilla: Proudest moment for Massive Bio on being recognized by The White House Cancer Moonshot
Blog
Jan 16, 2025, 22:31
Andrea Necchi: All you need to know about TAR-200
Blog
Jan 16, 2025, 22:27
Jutta Heix: Bridging innovations to improve clinical outcomes for cancer patients
Blog
Jan 16, 2025, 22:26
Vivek Subbiah: Novel Precision Oncology Trial Designs in Early Phase Clinical trials
Blog
Jan 16, 2025, 22:20
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Blog
Jan 16, 2025, 22:19
Don’t miss the ESMO Sarcoma and Rare Cancers Congress 2025!
Blog
Jan 16, 2025, 22:17
European School of Oncology Clinical Training Centres Fellowship programme
Celebrities
Jan 16, 2025, 17:18
Bob Uecker Dies at 90 from Small-Cell Lung Cancer
Insight
Jan 16, 2025, 16:45
The 2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
Insight
Jan 16, 2025, 16:28
ACS CAN Report: High Costs Block Critical Follow-Up Tests for Breast Cancer
Blog
Jan 16, 2025, 16:20
Genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC - ASGO Education
Science
Jan 16, 2025, 16:10
Neoadjuvant therapy in patients with left-sided resectable pancreatic cancer